Osteopontin predicts adverse right ventricular remodelling and dysfunction in pulmonary hypertension
Authors:
- 10 March 2012
- journal article
- research article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 42 (9) , 933-942
Abstract
Eur J Clin Invest 2012; 42 (9): 933–942 Background Osteopontin (OPN) was found upregulated in several heart failure models and appears to play an important role in myocardial remodelling. As we have previously demonstrated that OPN predicts mortality in patients with pulmonary hypertension (PH), we now evaluated whether OPN also predicts adverse right ventricular (RV) remodelling and dysfunction in PH.Methods We prospectively included 71 patients with PH of different etiology in this study. OPN plasma level were determined by ELISA and assessed for correlation with RV dilatation and dysfunction determined by echocardiography.Results OPN plasma values significantly correlated with RV end‐diastolic diameter, Tricuspid Annular Plane Systolic Excursion (TAPSE) and Tricuspid Annular Systolic Velocity (TASV) (r = 0·43, P = 0·0002; r = −0·46, P = 0·0006; r = −0·31, P = 0·02). Furthermore, stratification of our study population according to RV end‐diastolic diameter and RV dysfunction revealed that patients with enlarged and functionally impaired RV′s display higher OPN levels (956 ng/mL vs. 628 ng/mL, P = 0·0005; 1108 ng/mL vs. 792 ng/mL; P = 0·02). Next, we determined OPN cut‐off values for the detection of RV remodelling and dysfunction by receiver operating curve analyses and further stratified these parameters in a multivariate analysis. Here, OPN emerged as an independent predictor of RV dilatation and dysfunction. Finally, we demonstrate synergism of OPN and NT‐proBNP in the prediction of RV dilatation and dysfunction by calculation of the Rothman Synergy Index.Conclusion In summary, OPN predicts adverse RV remodelling and dysfunction in PH. Together with our previously published data regarding OPN’s value for the prognostication of death in PH, we believe that OPN can improve risk stratification in patients with PH beyond current assessment standards.Keywords
This publication has 26 references indexed in Scilit:
- Clinical and Prognostic Relevance of Echocardiographic Evaluation of Right Ventricular Geometry in Patients With Idiopathic Pulmonary Arterial HypertensionThe American Journal of Cardiology, 2011
- High-sensitive troponin T: a novel biomarker for prognosis and disease severity in patients with pulmonary arterial hypertensionClinical Science, 2010
- A catalogue of reporting guidelines for health researchEuropean Journal of Clinical Investigation, 2009
- Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)European Heart Journal, 2009
- Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodellingCardiovascular Research, 2009
- Osteopontin, a New Prognostic Biomarker in Patients With Chronic Heart FailureCirculation: Heart Failure, 2008
- Defining normal variables of right ventricular size and function in pulmonary hypertension: an echocardiographic studyPostgraduate Medical Journal, 2008
- Relationship Between Renal Function and Plasma Brain Natriuretic Peptide in Patients With Heart FailureJACC, 2006
- Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survivalJournal of Clinical Investigation, 2001
- Assessment of right ventricular function using two-dimensional echocardiographyAmerican Heart Journal, 1984